Episode 217: AI therapists, theta-bursts for depression, finerenone for CKD, and GLP-1s causing vision loss.

<p>This week, Henry, Kate, Gary and Mark talk about 4 great new studies: is using an AI chat therapist really that bad for youth, theta-burst stimulation for adults with major depressive disorder, finerenone in adults with CKD but not DM, and GLP-1 agonists and vision loss risk.</p>